Please wait while we open this resource.
K
Clinical reviews
ASPIRIN WITH OR WITHOUT STATIN IN INDIVIDUALS WITHOUT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE ACROSS RISK CATEGORIES
American College of Cardiology Foundation
PDF202312 pages1.8 MB
The research investigates the role of aspirin in primary prevention among adults who do not have atherosclerotic cardiovascular disease (ASCVD). It evaluates the impact of aspirin when used alone or in conjunction with statins, focusing on various ASCVD risk categories. The study utilizes randomized controlled trials to assess outcomes related to cardiovascular events, major bleeding, and mortality over a follow-up period of at least one year. The findings aim to clarify the risk-benefit balance of aspirin therapy in primary prevention settings.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology